| 英文品名 |
milatuzumab |
| 名称来源 |
p-INNList-98,2007;r-INNList-60,2008; |
| 化学表述 |
immunoglobulin G1, anti-[Homo sapiens CD74 (major histocompatibility complex class II invariant chain)] humanized monoclonal IMMU-115 (or hLL1); gamma1 heavy chain [humanized VH (Homo sapiens FR/Mus musculus CDR) [8.8.13] -Homo sapiens IGHG1*03] (223-219')-disulfide with kappa light chain [humanized V-KAPPA (Homo sapiens FR/Mus musculus CDR) [11.3.9] -Homo sapiens IGKC*01]; (229-229":232-232")-bisdisulfide dimer |
| CA登记号 |
899796-83-9 |
| 分 子 式 |
C6518H10066N1758O2020S40 |
| 结 构 式 |
|
| 品种类别 |
antineoplastic; |
|
